Cornell University College of Veterinary Medicine
University / teaching hospital
3 current cancer treatment or research opportunities
About Cornell veterinary oncology
Cornell's oncology service combines medical and radiation oncology with the Sprecher Institute for Comparative Cancer Research. Its teams study how cancers grow and spread, then test new drugs, imaging methods and treatments in dogs and cats receiving care at the teaching hospital.
Cornell oncology service →
Who the current listings are forDogs
Cancer types currently listedLymphoma, Oral Squamous Cell Carcinoma, Osteosarcoma
Where visits take placeCornell University Hospital for Animals, 930 Campus Rd, Ithaca, NY 14853
Current options at Cornell University College of Veterinary Medicine
Open an option to see who may qualify, locations, costs or coverage, contact details and the official source.
Trametinib for canine oral squamous cell carcinoma
Cornell University · USA
Current / recruiting
What is being offered: Dogs seen by Cornell University Hospital for Animals with diagnosed oral SCC are eligible for prescreen. Daily oral trametinib with scheduled follow-up through day 126. Cornell's live Clinical Trials roster and live contact form both currently offer this study.
Who may qualify: Confirmed cancer diagnosis required; Active tumor required
Costs / coverage: 🟢 Fully funded. All study visits, procedures and trametinib are free; dogs completing the study also receive a $1,000 credit toward standard-of-care SCC medical expenses.
Contact: PI Santiago Peralta, DVM, AVDC, FF-AVDC-OMFS; Cornell Dentistry/Oral Surgery or Oncology/Clinical Trials Coordinator, 607-253-3060; vet-research@cornell.edu
Location
- Cornell University Hospital for Animals, 930 Campus Rd, Ithaca, NY 14853
Official study / enrollment information →
SINE/Laverdia-CA1 (verdinexor) + carboplatin for canine osteosarcoma
Cornell University · USA
Recruiting
What is being offered: Carboplatin combined with Laverdia-CA1 (verdinexor), a selective inhibitor of nuclear export (SINE)
Who may qualify: Confirmed cancer diagnosis required; Prior surgery; Post amputation; Planned chemo
Costs / coverage: 🟡 Partially funded. Laverdia-CA1 is provided free; sponsor contributes $150 per carboplatin visit (up to $600) and $25 per bloodwork visit (up to $100), with a 10% bill discount. Owners pay all additional costs and unrelated tests/procedures.
Contact: Carol Frederick, Clinical Trials Coordinator; Cornell University Hospital for Animals, (607) 253-3060. Apply through the official study page.
Location
- Cornell University Hospital for Animals, 930 N Campus, Ithaca, NY 14853, Ithaca, NY
Official study / enrollment information →
Smart-Start therapy before CHOP for canine B-cell lymphoma
Cornell University College of Veterinary Medicine · USA
Actively recruiting on Cornell's current canine clinical-trials roster
What is being offered: Tumor-biology-selected pre-treatment drug followed by standard-of-care CHOP chemotherapy
Who may qualify: Confirmed cancer diagnosis required; Active tumor required; Planned chemo
May not qualify if: Prior local radiation; Prior immunotherapy
Costs / coverage: Study-specific tests and procedures have no extra owner cost. Cornell provides a 10% discount on standard-of-care chemotherapy visits and $1,000 toward chemotherapy costs; routine care not performed specifically for the study remains owner-paid.
Contact: Cornell Oncology / Clinical Trials Coordinator — 607-253-3060; vet-research@cornell.edu
Location
- Cornell University Hospital for Animals, 930 Campus Rd, Ithaca, NY 14853
Official study / enrollment information →
Before you contact the center
A listing here does not mean every pet will qualify. Enrollment can change, and the study team makes the final decision after reviewing your pet’s diagnosis, records and previous treatment.
Have the pathology report, recent imaging and treatment history ready. Ask whether a referral is required, which visits must happen in person and what the study pays for before making travel plans.
Check all options for your pet →
Free to use. No registration or paid report.
